About this trial
This randomised controlled study evaluates whether virtual reality (VR) can support patient comfort and help reduce anxiety and stress during subcutaneous venous port implantation in adult oncology patients. Patients will be assigned to standard care or standard care with VR intervention.
Subjective and objective measures of stress and discomfort will be collected, including the Visual Analog Scale (VAS) for self-reported procedural discomfort, physiological parameters (blood pressure, heart rate, variability), the STAI-6 questionnaire, and salivary cortisol.
The study aims to explore the potential of VR as a non-pharmacological, immersive tool to improve procedural experience and reduce psychological distress in patients undergo-ing minor oncological procedures.
Eligibility criteria
Qualifiers
Patients > 18 years of age
Signed Informed Consent Form
Patients Indicated for oncology treatment administration using subcutaneous port
Disqualifiers
Not signing of the Informed Consent Form
Patients < 18 years of age
Patients unsuitable for subcutaneous port implantation
Trial design
Treatments tested in this trial
- Virtual reality intervention
- Standard Care (in control arm)